Engineering CRISPR for emerging therapeutic applications
Authors:
- Xiaoqi SunXSXiaoqi Sun
- Zhuang LiuZLZhuang Liu
Open Access
- 30 October 2024
- journal article
- Published by Elsevier in EngMedicine
- Vol. 1 (3)
Abstract
No abstract availableFunding Information
- Higher Education Discipline Innovation Project
- National Key Research and Development Program of China (2021YFF0701800, 2020YFA0211100)
- Ministry of Education of the People's Republic of China
- Collaborative Innovation Center of Suzhou Nano Science and Technology
- National Natural Science Foundation of China (T2321005, 52032008)
This publication has 129 references indexed in Scilit:
- CRISPRa‐based activation of Fgf21 and Fndc5 ameliorates obesity by promoting adipocytes browningClinical and Translational Medicine, 2023
- Gene Editing in Hematopoietic Stem Cells2023
- Chromatin Remodeling of Colorectal Cancer Liver Metastasis is Mediated by an HGF‐PU.1‐DPP4 AxisAdvanced Science, 2021
- When liposomes met antibodies: Drug delivery and beyondAdvanced Drug Delivery Reviews, 2020
- The Heroes of CRISPRCell, 2016
- Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas SystemCell, 2015
- Crystal Structure of Cas9 in Complex with Guide RNA and Target DNACell, 2014
- CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in EukaryotesCell, 2013
- Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene ExpressionCell, 2013
- Intervening Sequences of Regularly Spaced Prokaryotic Repeats Derive from Foreign Genetic ElementsJournal of Molecular Evolution, 2005